LiorNesherMD
Infectious Disease • Houston, TXTransplant/Immunocompromised States
MD Anderson Cancer Center - Infectious Disease
Dr. Nesher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431 Fannin St
Msb 2.112
Houston, TX 77030Phone+1 713-500-6767
Education & Training
University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2013
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2011 - 2013
Soroka University Medical CenterChief resident - internal medicine, 2007 - 2008- Soroka University Medical CenterResidency Internal medicine, 2004 - 2007
- Ben Gurion University of the NegevClass of 2004
Publications & Presentations
PubMed
- Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.Hovav Azuly, Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira
Infectious Diseases and Therapy. 2024-12-09 - Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study.Nofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, Noga Hasson, Yaara Ben Ari
Infection. 2024-11-26 - Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients.Hersh D Ravkin, Lior Nesher
Infectious Diseases and Therapy. 2024-11-01
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
